Vermeulen L C, Bollinger K A, Antonopoulos J, Meek P D, Goshman L M, Ploetz P A
Department of Pharmacy, University of Wisconsin Hospital and Clinics, Madison 53792, USA.
Pharm Pract Manag Q. 1997 Jan;16(4):66-75.
As institutions continue to expand their drug policy development efforts in order to improve care and reduce cost, the use of multifaceted approaches offer several benefits. Population data on drug use support the need for policy action. The use of institutional outcomes data in conjunction with published evidence augments the process, and the consensus approach to guideline development engenders medical staff support. Such efforts, however, require significant dedication of human resources. Institutions with limited personnel to allocate to drug policy activities may consider increasing the depth of their efforts (using a multifaceted approach) while limiting the breadth of their efforts (only attempting one or two major targets per year, and doing them well).
随着各机构不断扩大其药物政策制定工作以改善医疗服务并降低成本，采用多方面的方法有诸多益处。药物使用的人群数据支持了采取政策行动的必要性。将机构成果数据与已发表的证据结合使用可增强这一过程，而指南制定的共识方法能获得医务人员的支持。然而，此类工作需要大量人力资源投入。人员有限、可分配到药物政策活动的机构，可考虑增加工作深度（采用多方面方法），同时限制工作广度（每年仅尝试一两个主要目标并做好）。
